Most Popular Products
CJC-1295 without DAC + Ipamorelin
10.0 USD ($)/Piece
Product Details:
- Taste Odorless
- Product Type Peptides
- Smell Other
- Grade Research Grade
- Physical Form Powder
- Shape other
- Application Pharmaceutical
- Click to View more
X
CJC-1295 without DAC + Ipamorelin Price And Quantity
- 10 Piece
- 10.0 USD ($)/Piece
CJC-1295 without DAC + Ipamorelin Product Specifications
- 2937190099
- other
- Pharmaceutical
- 4.5~6.5
- Other
- 18 Months
- CJC-1295 without DAC, Ipamorelin
- Peptides
- Freezer
- Not less than 99.00%
- Odorless
- A CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin blend combines a short-acting growth hormone-releasing hormone (GHRH) analog with a selective ghrelin receptor agonist to stimulate natural, pulsatile growth hormone (GH) release. Key Properties and Mechanism of Action Dual-Pathway Synergy: CJC-1295 (no DAC) targets GHRH receptors to amplify somatotroph signaling, while Ipamorelin acts on the ghrelin/growth hormone secretagogue receptor to trigger a distinct GH release pulse. Preserved Pulsatile Rhythm: Unlike versions with a Drug Affinity Complex (DAC) that bind to albumin and create a constant, long-acting elevation, No DAC (Mod GRF 1-29) clears rapidly to mimic the body's natural, pulsatile GH secretion pattern. Half-Life: CJC-1295 (No DAC): Approximately 30 minutes. Ipamorelin: Approximately 2 hours (preclinical estimate; human clinical data is limited). Hormonal Selectivity: Ipamorelin is noted for stimulating GH release without significantly spiking cortisol, prolactin, or appetite unlike older generation secretagogues like GHRP-2 or GHRP-6. Downstream Effects: Research focuses on stimulating endogenous GH and insulin-like growth factor 1 (IGF-1) axes, studied experimentally in relation to lean body mass, tissue recovery, and sleep architecture.
- White powder
- Powder
- Research Grade
- 863288-34-0/170851-70-4
- NO
- CJC-1295 without DAC (also known as Mod GRF 1-29) and Ipamorelin are both fully soluble in aqueous solutions, such as bacteriostatic water or sterile saline, which are standard for laboratory reconstitution.
- 206-141-6/227-005-2
- CJC-1295 without DAC (commonly known as Mod GRF 1-29) paired with Ipamorelin is a widely discussed research and clinical-adjacent stack designed to stimulate the body's natural, pulsatile release of growth hormone (GH). What is the Blend? CJC-1295 without DAC (Mod GRF 1-29): A synthetic 29-amino acid growth hormone-releasing hormone (GHRH) analog that binds to GHRH receptors on the pituitary gland to act as an "accelerator" for GH production. It has a short half-life of roughly 30 minutes, mimicking a natural, short-lived pulse. Ipamorelin: A selective growth hormone secretagogue (GHRP) and ghrelin receptor agonist that triggers a complementary GH release from the pituitary without significantly spiking cortisol or prolactin. The Synergistic Blend: Because they target two distinct receptor systems (GHRH and GHS-R), combining them produces a natural growth hormone pulse several times stronger than either peptide used alone. Pre-mixed vials (such as a 10mg blend containing 5mg of each) combine them in a 1:1 ratio for simultaneous injection.
CJC-1295 without DAC + Ipamorelin Trade Information
- Shenzhen or Guangzhou
- Western Union, Telegraphic Transfer (T/T)
- 10000 Piece Per Week
- 5 Days
- Yes
- Free samples available with shipping and taxes paid by the buyer
- 10 vials per kit
- North America, Australia, Asia, Western Europe
- All India
- GMP, ISO9001
Product Description
CJC-1295 (without DAC) and Ipamorelin (IPA) blend is a highly popular peptide blend within the anti-aging, fitness, and hormone optimization communities, used to stimulate the bodys own production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1).Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Peptide Preparations' category
![]() |
DALIAN HANDOM CHEMICALS CO.,LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |




